Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results from Randomized Phase 2b Core and Extension StudiesNeurology 2022 Jun 06;[EPub Ahead of Print], MS Freedman, C Pozzilli, EK Havrdova, A Lemle, M Burcklen, A Larbalestier, B Hennessy, T Sidorenko, A Vaclavkova, T Olsson
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.